Search

Your search keyword '"Yamashita, Kiyoshi"' showing total 12 results
Start Over Author "Yamashita, Kiyoshi" Publication Year Range Last 3 years
12 results on '"Yamashita, Kiyoshi"'

1. Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan

Author

Usuki, Kensuke, Kameda, Takuro, Kawano, Noriaki, Ito, Tomoki, Hashimoto, Yoshinori, Shide, Kotaro, Kawano, Hiroshi, Sekine, Masaaki, Toyama, Takanori, Iizuka, Hiromitsu, Sato, Seiichi, Takeuchi, Masanori, Ishizaki, Junzo, Maeda, Kouichi, Nakai, Michikazu, Yamashita, Kiyoshi, Kubuki, Yoko, and Shimoda, Kazuya

Published
2024
Full Text
View/download PDF

2. Case History of Soil–Cement Piles with H-Shaped Steels and Vertical Loading Tests

Author

Hamada, Junji, Taya, Yuji, Yamashita, Kiyoshi, Ikeda, Hidemi, di Prisco, Marco, Series Editor, Chen, Sheng-Hong, Series Editor, Vayas, Ioannis, Series Editor, Kumar Shukla, Sanjay, Series Editor, Sharma, Anuj, Series Editor, Kumar, Nagesh, Series Editor, Wang, Chien Ming, Series Editor, Cui, Zhen-Dong, Series Editor, Duc Long, Phung, editor, and Dung, Nguyen Tien, editor

Published
2024
Full Text
View/download PDF

3. The development of adult T cell leukemia/lymphoma in renal transplant recipients: report of two cases with literature review

Author

Kawano, Noriaki, Kyohei, Yamada, Miyoshi, Hiroaki, Yoshida, Noriaki, Ohshima, Kouichi, Arakawa, Fumiko, Nakashima, Kazutaka, Kameda, Takuro, Kogure, Yasunori, Ito, Yuta, Yoshida, Shuro, Kuriyama, Takuro, Nakaike, Takashi, Tochigi, Taro, Takigawa, Ken, Yamashita, Kiyoshi, Toyofuku, Atsushi, Manabe, Tatsuya, Doi, Atsushi, Terasaka, Soushi, Marutsuka, Kouske, Ochiai, Hidenobu, Kikuchi, Ikuo, Mori, Yasuo, Kataoka, Keisuke, Yoshizumi, Tomoharu, Yamauchi, Junji, Yamano, Yoshihisa, and Shimoda, Kazuya

Published
2023
Full Text
View/download PDF

8. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma

Author

Kameda, Takuro, primary, Kataoka, Keisuke, additional, Kamiunten, Ayako, additional, Hidaka, Michihiro, additional, Miyoshi, Hiroaki, additional, Nakano, Nobuaki, additional, Nosaka, Kisato, additional, Yoshimitsu, Makoto, additional, Yasunaga, Jun-ichirou, additional, Kogure, Yasunori, additional, Shide, Kotaro, additional, Miyahara, Masaharu, additional, Sakamoto, Takashi, additional, Akizuki, Keiichi, additional, Hidaka, Tomonori, additional, Kubuki, Yoko, additional, Koya, Junji, additional, Kawano, Noriaki, additional, Yamashita, Kiyoshi, additional, Kawano, Hiroshi, additional, Toyama, Takanori, additional, Maeda, Kouichi, additional, Marutsuka, Kosuke, additional, Imaizumi, Yoshitaka, additional, Kato, Koji, additional, Sugio, Takeshi, additional, Tokunaga, Masahito, additional, Tashiro, Yukie, additional, Takaori-Kondo, Akifumi, additional, Miyazaki, Yasushi, additional, Akashi, Koichi, additional, Ishitsuka, Kenji, additional, Matsuoka, Masao, additional, Ohshima, Koichi, additional, Watanabe, Toshiki, additional, Kitanaka, Akira, additional, Utsunomiya, Atae, additional, Ogawa, Seishi, additional, and Shimoda, Kazuya, additional

Published
2023
Full Text
View/download PDF

9. The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL)

Author

Kawano, Noriaki, primary, Shimonodan, Hidemi, additional, Nagahiro, Yuri, additional, Yoshida, Shuro, additional, Kuriyama, Takuro, additional, Takigawa, Ken, additional, Tochigi, Taro, additional, Nakaike, Takashi, additional, Makino, Shigeyoshi, additional, Yamashita, Kiyoshi, additional, Marutsuka, Kousuke, additional, Ochiai, Hidenobu, additional, Mori, Yasuo, additional, Shimoda, Kazuya, additional, Ohshima, Kouichi, additional, Mashiba, Koichi, additional, and Kikuchi, Ikuo, additional

Published
2023
Full Text
View/download PDF

10. Secondary Skin Cancer in a Case with Long-term Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Author

Kawano, Noriaki, primary, Nakamura, Shunou, additional, Mochida, Kousuke, additional, Yoshida, Shuro, additional, Kuriyama, Takuro, additional, Nakaike, Takashi, additional, Shimokawa, Tomonori, additional, Tochigi, Taro, additional, Yamashita, Kiyoshi, additional, Mashiba, Koichi, additional, Kikuchi, Ikuo, additional, Takarabe, Aina, additional, Moriguchi, Sayaka, additional, Mori, Yasuo, additional, Takenaka, Katsuto, additional, Shimoda, Kazuya, additional, Ochiai, Hidenobu, additional, and Amano, Masahiro, additional

Published
2022
Full Text
View/download PDF

11. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma

Author

Kameda, Takuro, primary, Shide, Kotaro, additional, Tahira, Yuki, additional, Sekine, Masaaki, additional, Sato, Seiichi, additional, Ishizaki, Junzo, additional, Takeuchi, Masanori, additional, Akizuki, Keiichi, additional, Kamiunten, Ayako, additional, Shimoda, Haruko, additional, Toyama, Takanori, additional, Maeda, Kouichi, additional, Yamashita, Kiyoshi, additional, Kawano, Noriaki, additional, Kawano, Hiroshi, additional, Hidaka, Tomonori, additional, Yamaguchi, Hideki, additional, Kubuki, Yoko, additional, Kitanaka, Akira, additional, Matsuoka, Hitoshi, additional, and Shimoda, Kazuya, additional

Published
2022
Full Text
View/download PDF

12. A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells.

Author

Takigawa K, Kawano N, Mori Y, Yamauchi T, Tochigi T, Miyawaki K, Mori K, Shimo M, Nakaike T, Yamashita K, Mashiba K, Kikuchi I, Marutsuka K, Ohshima K, Kato K, and Akashi K

Abstract

Secondary central nervous system (CNS) lymphomas typically require CNS-penetrating drugs; however, the available agents are limited with temporary effects and poor outcomes. Chimeric antigen receptor T (CAR-T) cell therapy (lisocabtagene maraleucel; liso-cel) has been used to treat a few cases of isolated secondary CNS lymphoma. Herein, we report the case of a 66-year-old male diagnosed with diffuse large B-cell lymphoma (Ann Arbor grade IV; R-IPI, good risk; CNS IPI: Intermediate risk) who achieved complete remission (CR) after six courses of R-CHOP therapy. Three months later, he presented with ptosis and eye movement disorder. Systemic CT and bone marrow examination revealed no lymphoma. Although cranial-enhanced MRI showed normal findings, an increased number of B-cells (51/μL) with the original lymphoma phenotype (CD19+CD79a+CD5-CD10-CD20-Igλ+) was detected in cerebrospinal fluid (CSF), indicating an isolated CNS relapse. Seven high-dose methotrexate courses led to partial response. Subsequently, the patient received CAR-T cell therapy with tolerable adverse events - cytokine release syndrome treated with tocilizumab, no immune effector cell-associated neurotoxicity syndrome, and bone marrow failure treated with granulocyte-colony stimulating factor and eltrombopag. Sequential flow cytometry revealed a high peak of CAR-T cells and the presence of residual CAR-T cells in the peripheral blood, indicating immune surveillance of CNS lymphoma by CAR-T cells. This treatment led to a second CR. This case is the first to validate the efficacy and safety of CAR-T cell therapy for isolated secondary CNS lymphoma in clinical practice. Future accumulation of evidence on the efficacy and safety of CAR-T cell therapy is essential., Competing Interests: The authors declare no conflict of interest. Disclosure forms provided by the authors are available on the website., (Copyright Ⓒ2024 Asia-Pacific Blood and Marrow Transplantation Group (APBMT).)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results